Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMPOR3G)

Drug Name
AC1LE05K Drug Info
Synonyms
2-cyclohexyl-N-(4H-1,2,4-triazol-3-yl)acetamide; MLS-0072999.0001; 2-cyclohexyl-N-(1H-1,2,4-triazol-5-yl)acetamide; 2-Cyclohexyl-N-(4H-[1,2,4]triazol-3-yl)-acetamide; AC1LE05K; Cambridge id 6726786; MLS000527850; cid_704227; SCHEMBL13934556; CHEMBL1408713; BDBM51399; HMS3315G01; HMS2154C10; ZINC5731798; STK222766; AKOS000643541; MCULE-3724123277; SMR000120424; BAS 04087149; EU-0013407; MLS-0072999.0002; 2-cyclohexyl-N-(1H-1,2,4-triazol-5-yl)ethanamide; Z57261898; 432007-38-0
Cross-matching ID
PubChem CID
704227
TTD Drug ID
DMPOR3G

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Endoplasmic reticulum to nucleus signaling 1 (ERN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ORIN1001 DM27RXS Metastatic breast cancer 2C6Y Phase 1/2 [2]
US9040714, 7 DM53Z4I N. A. N. A. Patented [3]
T8361 DM86BDS N. A. N. A. Patented [4]
US8614253, 29-1 DMJKFVU N. A. N. A. Patented [5]
US8614253, 32-5 DMSQODK N. A. N. A. Patented [4]
US8614253, 29-19 DMVI83P N. A. N. A. Patented [6]
879325-11-8 DMP04Z6 N. A. N. A. Patented [3]
US8614253, 32-4 DMRSP2M N. A. N. A. Patented [6]
BB 0223767 DM2DT6L N. A. N. A. Patented [4]
US9241942, 32-12 DM8GW54 N. A. N. A. Patented [6]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Endoplasmic reticulum to nucleus signaling 1 (ERN1) TTOJ9QL ERN1_HUMAN Inhibitor [1]

References

1 IRE-1 inhibitors. US9693992.
2 Clinical pipeline report, company report or official report of Orinove.
3 IRE-1 inhibitors. US9040714.
4 IRE-1 inhibitors. US8614253.
5 IRE-1 inhibitors. US9241942.
6 IRE-1 inhibitors. US9493435.